Conor gains in UK
This article was originally published in The Gray Sheet
Executive Summary
UK High Court of Justice invalidates Boston Scientific-licensed Angiotech patent for paclitaxel-eluting stent in response to a revocation request by Conor Medsystems. Angiotech says it will appeal the decision, which only affects the UK patent. Conor received a CE Mark for marketing its CoStar paclitaxel-eluting stent in Europe Feb. 17 (1"The Gray Sheet" Feb. 20, 2006, p. 7)...